Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study
American Journal of Translational Research · 2025 · 17 (3) · 2240-2249
DOI: 10.62347/yopp4162 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2025. Verfasst von Haiyan Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Psychiatry, The Third People's Hospital of Yongkang No. 18 Feifeng Road, Xicheng Street, Yongkang City, Jinhua 321300, Zhejia…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Psychiatry, The Third People's Hospital of Yongkang No. 18 Feifeng Road, Xicheng Street, Yongkang City, Jinhua 321300, Zhejiang, China.
Zitieren
APA
Wang, H., & Lv, P. (2025). Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study. American Journal of Translational Research, 17(3), 2240-2249. https://doi.org/10.62347/yopp4162
Vancouver
Wang H, Lv P. Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study. American Journal of Translational Research. 2025;17(3):2240-2249. doi:10.62347/yopp4162
BibTeX
@article{Wang2025,
author = {Wang, Haiyan and Lv, Pingping},
title = {Safety and efficacy of rivastigmine and memantine combined for treatment of patients with Alzheimer’s disease: a retrospective study},
journal = {American Journal of Translational Research},
year = {2025},
volume = {17},
number = {3},
pages = {2240--2249},
doi = {10.62347/yopp4162}
}
EUVIMED